The data presented here provide the first evidence that ISL attenuates the development of atherosclerosis and hepatic steatosis in Western diet-fed apoE−/− mice, and the potential mechanism may include amelioration of lipid metabolism, inflammation, and oxidative status. The gene discussed is APOE; the disease is atherosclerosis.